Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndromeLaurence Fardet, Lionel Galicier, Olivier Lambotte, et al.
British Journal of Haematology|August 27, 2014
Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposideMarc Arca, Laurence Fardet, Lionel Galicier, et al.
British Journal of Haematology|February 11, 2022
TTP: From empiricism for an enigmatic disease to targeted molecular therapiesNuno A G Graça, Bérangère S Joly, Jan Voorberg, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassayNicolas Beranger, Sandrine Benghezal, Bérangère S Joly, et al.
American Journal of Hematology|October 21, 2004
Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptidesPaul Coppo, Jean-Pierre Clauvel, Djaouida Bengoufa, et al.
Thrombosis Research|July 23, 2019
Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpuraNicolas Béranger, Sandrine Benghezal, Sylvaine Savigny, et al.
Annales De Medecine Interne|September 10, 2002
[Pathophysiology of thrombotic microangiopathies: current understanding]Paul Coppo, Agnès Veyradier, Marie-Agnès Durey, et al.
European Journal of Internal Medicine|December 8, 2004
Antineutrophil cytoplasmic antibody-associated neutropeniaPaul Coppo, David Ghez, Vincent Fuentes, et al.
Journal of Nephrology|February 22, 2021
Immune-mediated thrombotic thrombocytopenic purpura in childhood treated by caplacizumab, about 3 casesJulie Boudali, Benjamin Hallak, Marie Haeck, et al.
Haematologica|April 21, 2018
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggersJohana Hrdinová, Silvia D'Angelo, Nuno A G Graça, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndromeLaurence Fardet, Lionel Galicier, Olivier Lambotte, et al.
British Journal of Haematology|August 27, 2014
Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposideMarc Arca, Laurence Fardet, Lionel Galicier, et al.
British Journal of Haematology|February 11, 2022
TTP: From empiricism for an enigmatic disease to targeted molecular therapiesNuno A G Graça, Bérangère S Joly, Jan Voorberg, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassayNicolas Beranger, Sandrine Benghezal, Bérangère S Joly, et al.
American Journal of Hematology|October 21, 2004
Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptidesPaul Coppo, Jean-Pierre Clauvel, Djaouida Bengoufa, et al.
Thrombosis Research|July 23, 2019
Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpuraNicolas Béranger, Sandrine Benghezal, Sylvaine Savigny, et al.
Annales De Medecine Interne|September 10, 2002
[Pathophysiology of thrombotic microangiopathies: current understanding]Paul Coppo, Agnès Veyradier, Marie-Agnès Durey, et al.
European Journal of Internal Medicine|December 8, 2004
Antineutrophil cytoplasmic antibody-associated neutropeniaPaul Coppo, David Ghez, Vincent Fuentes, et al.
Journal of Nephrology|February 22, 2021
Immune-mediated thrombotic thrombocytopenic purpura in childhood treated by caplacizumab, about 3 casesJulie Boudali, Benjamin Hallak, Marie Haeck, et al.
Haematologica|April 21, 2018
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggersJohana Hrdinová, Silvia D'Angelo, Nuno A G Graça, et al.
Pageof 20